ocal infiltration with anesthetics vs placebo in patients with elective total hip replacement (thr) in fast-track protocol
Completed
- Conditions
- new hippain management10023213
- Registration Number
- NL-OMON41707
- Lead Sponsor
- Spaarne Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 160
Inclusion Criteria
-in writing given informed consent ;-over 18 years of age ;- operation indication: primary coxarthrosis ;-Dutch speaking and understanding ;-Spinal anaesthesia ;-patients who go home after surgery (secondary outcome length of stay)
Exclusion Criteria
-Patients who within 12 months prior to the surgery were opioid-dependent. ;-malignancies. ;-Patients with co-morbidities which may affect the possible pain perception (in the prehistory: CVA or a psychiatric disorder). ;-Patients with allergies to ropivacaine ;-ASA 3-4 ;-Patients with a peroperatieve complication occurs which interferes with the normal mobilization and pain experience (fractures, vascular/nerve injury
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary endpoint is the NRS pain score 24 hours postoperatively at rest</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary endpoints are the-NRS scores for pain (from 24 hours) to 48 hours<br /><br>postoperatively<br /><br>-HOOS (pre OK and 6 WKS post)<br /><br>-SF12 (pre OK and 6 WKS post)<br /><br>-Oxford Hip score (pre OK and 6 WKS post)<br /><br>-length of stay<br /><br>-Presence of nausea, vomiting, bladder retention<br /><br>-Complications<br /><br>-Use analgesics: PCA-use/opiates<br /><br>- NRS pain during rest and mobilization till 48 hours postoepratively</p><br>